Mutant Gene Stops At-Risk People From Getting Alzheimer’s

By Dennis Thompson HealthDay Reporter WEDNESDAY, June 1, 2022 (HealthDay News) — The APOE4 gene is the most powerful genetic factor driving a person’s risk for developing late-onset Alzheimer’s disease.…

Biogen C.E.O. to Step Down Following Launch of Alzheimer’s Drug, Aduhelm

Biogen said on Tuesday that it will replace its chief executive and effectively give up on marketing a high-profile Alzheimer’s drug that has been a commercial failure since its controversial…

Women responded better to early Alzheimer’s interventions, study finds

“Two out of every three brains affected by Alzheimer’s disease are women’s brains,” said Dr. Richard Isaacson, director of the Alzheimer’s Prevention Clinic in the Center for Brain Health at…

Alzheimer’s Disease Fast Facts – CNN

Alzheimer’s disease is the most common form of dementia, which is a general term for the loss of memory and intellectual abilities. Alzheimer’s disease is fatal and there is no…

Medicare Will Only Cover New Alzheimer’s Drug in Trials

April 8, 2022 — Federal officials have made their final decision: Medicare will only pay for patients to get the new Alzheimer’s drug aducanumab (Aduhelm) if the patients are participating…

Alzheimer’s Drug Aduhelm Faces Crucial Medicare Decision

Posts supporting coverage include comments from people who have consulted for Biogen, like Dr. Jeffrey Cummings, a research professor in the department of brain health at the University of Nevada…